Premier Alternatives

Magnus Medical

Burlingame, CA · Founded 2017 · Privately Held (backing)

Developer of a brain stimulation technology designed to treat neurological and psychiatric disorders. Magnus Medical is based in Burlingame, CA and was founded in 2017. Its last reported valuation was $65 million in Dec 2020. It has raised $89 million across 2 recorded rounds; the latest was a $49 million early-stage round in May 2025.

Last reported valuation
$65.0M
Oct 2026
Priced at
—
Total raised
$89.0M
Last round
Early Stage VC
May 2025

Magnus Medical key facts

as of Oct 2026
  • Developer of a brain stimulation technology designed to treat neurological and psychiatric disorders.
  • Magnus Medical is valued at approximately $65.0M as of Oct 2026 (last reported valuation).
  • It has raised $89.0M across 2 recorded rounds; the latest was Early Stage VC ($49.0M) in May 2025.
  • Notable investors include Dolby Family Ventures, JAZZ Venture Partners, Maj Invest, Red Tree Venture Capital, Still Capital Partners.
  • Magnus Medical has filed 2 Form Ds with the SEC, most recently May 2025 ($23.7M sold to 6 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$65.0M

Magnus Medical's last reported valuation, Dec 2020. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Magnus Medical with a free account
  • ·Watch Magnus Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Magnus Medical funding rounds

2 rounds
May 2025Early Stage VC$49.0MSEC filing▮
Feb 2025Early Stage VC$40.3MSEC filing▮
Full funding history →

Magnus Medical valuation

Magnus Medical's last reported valuation was $65 million in Dec 2020. No priced round, secondary trade or fund mark has surfaced since.

How much has Magnus Medical raised?

Magnus Medical has raised $89 million across 2 recorded rounds since 2025. The largest was a $49 million early-stage round in May 2025.

Magnus Medical has filed 2 Form Ds with the SEC, most recently in May 2025 ($23.7 million sold to 6 investors).

Magnus Medical investors

5 investors are on record for Magnus Medical, including Dolby Family Ventures, JAZZ Venture Partners, Maj Invest and Red Tree Venture Capital. The early-stage round in May 2025 drew 10 investors.

About Magnus Medical

Developer of a brain stimulation technology designed to treat neurological and psychiatric disorders. The company's technology is a novel treatment that has demonstrated profound and rapid results caused by identifiable changes in brain networks, enabling patients to manage their symptoms acutely and restore and sustain mental health.

Sector
Healthcare
HQ
Burlingame, CA, United States
Founded
2017
Employees
49
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.